CCN2 and cardiovascular disorder: Another aspect of the action of trimetazidine mechanism that may be crucial for people with cardiovascular disease, including those who have chronic heart failure (CHF), is its direct suppression of cardiac fibrosis through enhancing connective tissue growth factor (CTGF) [13].